Purer fentanyl won’t solve the U.S. overdose death crisis, study says
Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds newsletter.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by STAT News; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersWhy Sellas' experimental immunotherapy study is a blowup waiting to happen.
By Chella·4h ago
Why it mattersDemocrats are mapping out their post-election strategy, and see health care probes as a winning issue.
By Chella·1d ago
Why it mattersIn this edition of STAT Health Tech: Zocdoc enables appointment scheduling from chatbots and health plan websites, and more.
By Chella·2h ago
Why it mattersWhy a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody treatment for atopic dermatitis.
By Chella·4h ago